Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-36.33%
202419.05%
2023-29.74%
2022-22.30%
202111.00%
2020929.51%
2019-7.66%
201815.36%
2017-72.05%
2016-38.49%